253 related articles for article (PubMed ID: 23369087)
1. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
2. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.
Yousefi M; Khosravi-Eghbal R; Reza Mahmoudi A; Jeddi-Tehrani M; Rabbani H; Shokri F
Hum Vaccin Immunother; 2014; 10(2):344-51. PubMed ID: 24126015
[TBL] [Abstract][Full Text] [Related]
4. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
5. Comparative human and mouse antibody responses against tetanus toxin at clonal level.
Yousefi M; Younesi V; Bayat AA; Jadidi-Niaragh F; Abbasi E; Razavi A; Khosravi-Eghbal R; Asgarian-Omran H; Shokri F
J Immunotoxicol; 2016; 13(2):243-8. PubMed ID: 25990600
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
[TBL] [Abstract][Full Text] [Related]
7. Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice.
Zhang G; Yu R; Chi X; Chen Z; Hao M; Du P; Fan P; Liu Y; Dong Y; Fang T; Chen Y; Song X; Liu S; Li J; Yu C; Chen W
Int Immunopharmacol; 2021 Feb; 91():107297. PubMed ID: 33360088
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
Liu XY; Wei DK; Li ZY; Lu JS; Xie XM; Yu YZ; Pang XB
Vaccine; 2023 Nov; 41(46):6834-6841. PubMed ID: 37816654
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C.
Gustafsson B; Whitmore E; Tiru M
Hybridoma; 1993 Dec; 12(6):699-708. PubMed ID: 8288271
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
11. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
Minamitani T; Kiyose K; Otsubo R; Ito T; Akiba H; Furuta RA; Inoue T; Tsumoto K; Satake M; Yasui T
Sci Rep; 2021 Jun; 11(1):12134. PubMed ID: 34108521
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
Schoepe H; Wieler LH; Bauerfeind R; Schlapp T; Potschka H; Hehnen HR; Baljer G
Microb Pathog; 1997 Jul; 23(1):1-10. PubMed ID: 9250775
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of tetanus toxin neutralization by native human monoclonal antibodies.
Wang Y; Wu C; Yu J; Lin S; Liu T; Zan L; Li N; Hong P; Wang X; Jia Z; Li J; Wang Y; Zhang M; Yuan X; Li C; Xu W; Zheng W; Wang X; Liao HX
Cell Rep; 2021 May; 35(5):109070. PubMed ID: 33951441
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.
Luo P; Qin L; Mao X; Chen L; Yu S; Li Q; Liu W; Zhang W; Gu J; Zou Q
Vaccine; 2012 Oct; 30(45):6449-55. PubMed ID: 22889825
[TBL] [Abstract][Full Text] [Related]
16. Protective murine monoclonal antibodies to tetanus toxin.
Shang HF; Liau MY; Chow MF; Jiang SY; Chen SC; Yeh MY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):199-209. PubMed ID: 3151481
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tetanus toxin fragment C binding to ganglioside G(T1b) by monoclonal antibodies recognizing different epitopes.
Fitzsimmons SP; Clark KC; Wilkerson R; Shapiro MA
Vaccine; 2000 Aug; 19(1):114-21. PubMed ID: 10924793
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies to tetanus toxin.
Sheppard AJ; Cussell D; Hughes M
Infect Immun; 1984 Feb; 43(2):710-4. PubMed ID: 6198285
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.
Ziegler-Heitbrock HW; Reiter C; Trenkmann J; Fütterer A; Riethmüller G
Hybridoma; 1986; 5(1):21-31. PubMed ID: 2420699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
